Supplementary Table 1.
Additional Survey Responses Specific to COVID-19 Vaccination
| Survey items | Local (n = 236) % (fraction) |
Social media (n = 670) % (fraction) |
|---|---|---|
| 15. COVID-19 vaccine will be important for health of others | 96.2 (227/236) | 90.9 (609/670) |
| 16. COVID-19 vaccine will be important for my health | 95.8 (226/236) | 83.6 (560/670) |
| 17. Someone close to me was negatively affected by COVID-19 | 48.7 (115/236) | 46.3 (310/670) |
| 18. My IBD provider’s recommendation is an important factor in my decision to take the COVID-19 vaccine | 92.0 (217/236) | 80.6 (540/670) |
| 19. What can IBD providers do to better inform you about the COVID-19 vaccines?a | ||
| Have a conversation with me about risks/benefits | 58.9 (139/236) | 67.5 (452/670) |
| Provide me an informational handout | 31.4 (74/236) | 32.8 (220/670) |
| Provide me data about vaccine safety/efficacy among patients with IBD or other autoimmune disorders | 66.5 (157/236) | 71.3 (478/670) |
| Provide me data about vaccine safety/efficacy among patients with IBD who take my medication(s) | 67.4 (159/236) | 71.5 (479/670) |
| Nothing | 9.3 (22/236) | 10.0 (67/670) |
IBD, inflammatory bowel disease.
a
Respondents could choose multiple options for survey item #19.